Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-01-19 to 2023-01-20
Current total value of award: $93.24
Description: 4559652709!ARTIFICIAL TEARS SOLU